J Korean Med Assoc Search

CLOSE


J Korean Med Assoc > Volume 54(10); 2011 > Article
Journal of the Korean Medical Association 2011;54(10):1020-1027.
DOI: https://doi.org/10.5124/jkma.2011.54.10.1020   
Evidence-based management and treatment of high-risk individuals with pre-diabetes
Ki Hong Chun
Department of Preventive Medicine and Public Health, Ajou University School of Medicine, Suwon, Korea. ajoujkh@ajou.ac.kr
Abstract
The prevalence of type 2 diabetes (T2DM) has increased dramatically during the last decade, especially in Asian population. The control of hyperglycemia is very important for diabetes patients. Prevention of T2DM should be a major public health goal because of its substantial effect on heath. Treatment of high-risk individuals with impaired fasting glucose and impaired glucose tolerance to prevent T2DM has important medical, economic, social, and human implications. Identifying risk factors affecting transition diabetes is thus very important. Having defined a patient population at high-risk for developing diabetes, the intensive intervention of diet, physical activity, lifestyle modification, and drug therapy (metformin) can substantially affect the delay and prevention of T2DM. Tight glucose control has the potential to reduce the incidence and prevalence of T2DM.
Key Words: Impaired fasting glucose, Impaired glucose tolerance, Prediabetes state, Evidence-based intervention
 


ABOUT
ARTICLE CATEGORY

Browse all articles >

ARCHIVES
FOR CONTRIBUTORS
Editorial Office
Samgu B/D 7F, 40 Cheongpa-ro, Youngsan-gu, Seoul 04373, Korea
Tel: +82-1566-2844    Fax: +82-2-792-5208    E-mail: jkmamaster@kma.org                

Copyright © 2022 by Korean Medical Association.

Developed in M2PI

Close layer
prev next